Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-06-20

Neuromuscular Blocking Agents

Skeletal Muscle Relaxants — Competitive & Depolarising Block, Reversal, Monitoring & Recent Advances

Past RGUHS + DNB + MPMSU + MUHS · 11 DNBOct '24 DNBOct '23 RGUHSNov '22 MPMSUAug '21 MUHSWinter '21 RGUHSNov '20 RGUHSNov '19 MPMSUJun '17 MPMSU2015 MUHSSummer '15 RGUHSOct '09

Introduction

  • Skeletal muscle relaxants — drugs that reduce muscle tone or produce paralysis by acting either peripherally at the neuromuscular junction (NMJ) / muscle fibre, or centrally in the cerebrospinal axis.
  • Neuromuscular blocking agents (NMBAs) — the peripherally acting, NMJ-blocking subset used chiefly with general anaesthetics to relax skeletal muscle for surgery and to facilitate endotracheal intubation; being charged quaternary compounds they do not cross the blood–brain barrier, so they lack CNS activity, analgesia or sedation.
  • Two clinical classes — depolarising (only succinylcholine in general use) and non-depolarising / competitive (tubocurarine, the aminosteroids and the benzylisoquinoliniums).
  • Historical note — curare = South-American arrow poison; Claude Bernard localised its action to the NMJ; Griffith & Johnson introduced curare for surgical relaxation in 1942.
Continue reading

Neuromuscular Blocking Agents

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.